PharmAthene to Present at the UBS Global Life Sciences Conference on Thursday September 25, 2008

Tuesday, September 16, 2008 General News J E 4
ANNAPOLIS, Md., Sept. 16 PharmAthene, Inc.,(Amex: PIP) a biodefense company developing medical countermeasures againstbiological and chemical threats, announced today that David P. Wright,President and Chief Executive Officer of PharmAthene, will present at the UBSGlobal Life Sciences Conference on September 25, 2008 at 1:30 p.m. in BallroomE at The Grant Hyatt hotel in New York.

PharmAthene's presentation will be available via webcast on the company'swebsite at A link to access the webcast will beaccessible from the Investor Relations section of the website under News &Events / Presentations. For assistance, contact Stacey Jurchison at410-269-2610.

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States andits allies by developing and commercializing medical countermeasures againstbiological and chemical weapons. PharmAthene's lead product developmentprograms include:

For more information about PharmAthene, please visit SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rPA anthrax vaccine -- Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection -- Protexia(R) - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents -- RypVax(TM) - a recombinant dual antigen vaccine for plague

SOURCE PharmAthene, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Centene Foundation for Quality Healthcare Awards G...
DST Health Solutions Receives URAC Health Utilizat...